Overview of Swissmedic Vigilance News

Permalink dieser Seite:
www.swissmedic.ch/vigilance-news-de

Current Editions

28.05.2024

Swissmedic Vigilance News Edition 32

In this edition:

  • Paclitaxel-induced cystoid macular oedema
  • Chemotherapy-associated severe hypertriglyceridaemia
  • Spider-like skin reactions following bortezomib (Velcade®)
  • Potential increased risk of neurodevelopmental disorders (NDD) in children whose fathers were treated with valproate

28.11.2023

Swissmedic Vigilance-News Edition 31

In this edition:

  • Pregnancy outcomes after GLP-1 agonist exposure in early pregnancy
  • Drug-induced pancreatitis
  • Febuxostat and azathioprine: a rare interaction
  • Kounis syndrome: a less familiar ADR
  • Statistical Review 2022

30.05.2023

Swissmedic Vigilance-News Edition 30

In this edition:

  • Checkpoint inhibitors: pregnancy-related outcomes
  • JAK inhibitors: risk minimisation / dosage individualisation
  • COVID-19 vaccines: myocarditis in elderly patients / adverse reactions after vaccination with bivalent vaccines
  • Haemovigilance: incorrect blood component transfused and near misses

22.11.2022

Vigilance-News Edition 29

In this edition:

  • Reports of urticaria after booster vaccination with Spikevax
  • Contrast-induced neurotoxicity
  • Swiss Haemovigilance System: Regulatory aspects and transfusion reactions
  • Statistical Review 2021: Pharmacovigilance for human medicinal products, vaccinovigilance, vigilance for veterinary medicinal products

23.05.2022

Vigilance-News Edition 28

In this edition:

COVID-19 immunisation:

  • Modification of the Information for healthcare professionals since authorisation
  • Myocarditis, thromboembolic events, multiple sclerosis
  • Persistent headache
  • Methods of signal detection / ”Observed versus expected” analyses

29.11.2021

Vigilance-News Edition 27

In this edition:

COVID-19 immunisation:

  • Myocarditis/pericarditis: Case reports received by Swissmedic
  • Menstrual disorders – facts, possible causes, unanswered questions
  • Recent study findings and recommendations
    for vaccination of pregnant women
  • International cooperation
    in the area of pharmacovigilance

29.06.2021

Vigilance-News Edition 26

In this edition:

  • COVID-19 vaccines: reporting suspected side effects correctly
  • Case report “COVID arm”
  • AEFI after immunisation with COVID-19 vaccines: Herpes zoster, neuralgic amyotrophy, immune thrombocytopenia

15.12.2020

Vigilance-News Edition 25

In this edition:

  • New reporting routes for adverse drug reaction reports
  • CRS associated with immune checkpoint inhibitors
  • Intravenous iron and osteomalacia
  • Signal management

19.05.2020

Vigilance-News Edition 24

Keywords in this edition: Guest article: valproate during pregnancy, Asthma triggered by Aspirin?, Nitro-resistant, triptan-induced acute coronary syndrome, ICH E2D Guideline revision

13.11.2019

Vigilance-News Edition 23

Keywords in this edition:
Oral anticoagulants under real-world conditions, ADR in the elderly, Haemophagocytic lymphohistiocytosis, Case report, Statistical Review 2018

22.05.2019

Vigilance News Edition 22

Keywords in this edition: Current case report, WHO - Annual pharmacovigilance meeting, Medicinal product risks, Information for patients, Collaboration on the safety of medicines

06.11.2018

Vigilance News Edition 21

Keywords in this edition: Isotretinoin, DOAC, confusions amphotericin B formulations, guest articles RPVC, transfusion practice, statistical review 2017

07.06.2018

Vigilance News Edition 20

Special issue: The history and development of pharmacovigilance in Switzerland over the last three decades

Previous issues